Form 4: Lori Goltermann Acquires LifeStance Health Stock

Lori Goltermann, a Director at LifeStance Health Group, Inc., acquired 35,492 restricted stock units on July 2, 2026.

Summary

• Lori Goltermann, a Director at LifeStance Health Group, Inc. (LFST), acquired 35,492 restricted stock units (RSUs) on July 2, 2026.
• These RSUs represent a contingent right to receive one share of the Issuer's common stock.
• The acquisition was reported as a non-derivative transaction with a reported value of $0.00.
• Following this transaction, Goltermann beneficially owns 35,492 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents an insider acquisition of stock, which can be interpreted as a sign of confidence, but it does not provide new financial performance data.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of 35,492 RSUs indicates a significant stake taken by a key insider.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly by directors, are common in the healthcare services sector as a signal of commitment and belief in the company's growth trajectory, especially for companies like LifeStance Health that operate in a competitive and evolving market.

Stakeholder Impact

• Shareholders may view this acquisition positively, interpreting it as a sign of confidence from a company director.
• Employees may see this as a positive signal regarding the company's stability and future prospects.

Key Dates

Keywords

LifeStance Health, LFST, Form 4, Insider Trading, Restricted Stock Units, Director, Securities Acquisition